Bruker Corporation: Bruker is Ushering in the Age of Spatial Single-Cell Metabolomics
Novel unbiased, in situ Spatial Single-Cell Metabolomics (SSCM) enables high-throughput metabolic tissue characterization with single-cell resolution New 5 µm microGRID technology for timsTOF
Baden Wüberg Petra Scheffer Theodore Alexandrov Molecular Medicine Partnership Unit Bioinnovation Institute International Conference Of The Metabolomics Society
Source: finanznachrichten.de